A study assessing UBX-1967
Latest Information Update: 15 Nov 2019
At a glance
- Drugs UBX 1967 (Primary)
- Indications Age-related macular degeneration; Diabetic macular oedema; Diabetic retinopathy; Glaucoma
- Focus Adverse reactions
Most Recent Events
- 15 Nov 2019 New trial record
- 06 Nov 2019 According to an UNITY BIOTECHNOLOGY media release, the company plans to file an IND in early 2020.